Chengxue Dang

3.3k total citations · 1 hit paper
106 papers, 2.0k citations indexed

About

Chengxue Dang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chengxue Dang has authored 106 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 37 papers in Oncology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chengxue Dang's work include Gastric Cancer Management and Outcomes (21 papers), Cancer-related molecular mechanisms research (16 papers) and RNA modifications and cancer (14 papers). Chengxue Dang is often cited by papers focused on Gastric Cancer Management and Outcomes (21 papers), Cancer-related molecular mechanisms research (16 papers) and RNA modifications and cancer (14 papers). Chengxue Dang collaborates with scholars based in China, Japan and United States. Chengxue Dang's co-authors include Hao Zhang, Yongchun Song, Zhangjian Zhou, Kun Zhu, Dongmei Diao, Dawei Yuan, Xin Xie, Rong Yan, Yao Cheng and Qingyong Ma and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chengxue Dang

105 papers receiving 2.0k citations

Hit Papers

The global, regional and national burden of peptic ulcer ... 2022 2026 2023 2024 2022 40 80 120
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study
    2022 130 citations Xin Xie, Zhangjian Zhou et al. profile →

Peers

Chengxue Dang
Wei Song China
Chie Takasu Japan
Chew-Wun Wu Taiwan
Liang-Shun Wang Taiwan
Kun‐Chun Chiang Taiwan
Graham P. Pidgeon Ireland
Lin Jiang China
Xu Guan China
Hao Weng China
Elizabeth Half Israel
Wei Song China
Chengxue Dang
Citations per year, relative to Chengxue Dang Chengxue Dang (= 1×) peers Wei Song

Countries citing papers authored by Chengxue Dang

Since Specialization
Citations

This map shows the geographic impact of Chengxue Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxue Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxue Dang more than expected).

Fields of papers citing papers by Chengxue Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengxue Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxue Dang. The network helps show where Chengxue Dang may publish in the future.

Co-authorship network of co-authors of Chengxue Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengxue Dang. A scholar is included among the top collaborators of Chengxue Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxue Dang. Chengxue Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xueni, Yong Yang, Xin Xie, et al.. (2024). Chronic low-dose deltamethrin exposure induces colon injury and aggravates DSS-induced colitis via promoting cellular senescence. Ecotoxicology and Environmental Safety. 274. 116214–116214. 5 indexed citations
2.
3.
4.
Zhu, Kun, et al.. (2022). Knockdown of RSPH14 inhibits proliferation, migration, and invasion and promotes apoptosis of hepatocellular carcinoma via RelA. Cancer Cell International. 22(1). 129–129. 6 indexed citations
5.
Zhang, Xin, et al.. (2022). Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection. BMC Cancer. 22(1). 684–684. 26 indexed citations
6.
Wang, Jianling, Hongxin Cao, Peng Feng, et al.. (2022). GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway. Cell Death and Disease. 13(8). 751–751. 4 indexed citations
7.
Zhou, Zhangjian, Xin Xie, Xuan Wang, et al.. (2021). Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer. Frontiers in Genetics. 12. 623424–623424. 22 indexed citations
8.
Wang, Jingyuan, Chengxue Dang, Hao Zhang, et al.. (2021). The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data. Urologia Internationalis. 106(4). 344–351. 8 indexed citations
9.
Zhang, Yongxi, Huijie Jia, Zhiang Liu, et al.. (2021). D-MT prompts the anti-tumor effect of oxaliplatin by inhibiting IDO expression in a mouse model of colon cancer. International Immunopharmacology. 101(Pt A). 108203–108203. 8 indexed citations
10.
Ma, Xiaobin, Chengxue Dang, Weili Min, et al.. (2019). Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression. Breast Cancer Research and Treatment. 176(1). 109–117. 15 indexed citations
11.
Xie, Xin, Zhangjian Zhou, Yongchun Song, Chengxue Dang, & Hao Zhang. (2017). Surgical Management and Prognostic Prediction of Adenocarcinoma of Jejunum and Ileum. Scientific Reports. 7(1). 15163–15163. 3 indexed citations
12.
Xu, Gang & Chengxue Dang. (2017). CMTM5 is downregulated and suppresses tumour growth in hepatocellular carcinoma through regulating PI3K-AKT signalling. Cancer Cell International. 17(1). 113–113. 28 indexed citations
13.
Qiao, Zhe, Chengxue Dang, Bin Zhou, et al.. (2016). Downregulation of O-linked N-acetylglucosamine transferase by RNA interference decreases MMP9 expression in human esophageal cancer cells. Oncology Letters. 11(5). 3317–3323. 8 indexed citations
14.
Xie, Xin, Zhangjian Zhou, Yongchun Song, et al.. (2016). The Management and Prognostic Prediction of Adenocarcinoma of Appendix. Scientific Reports. 6(1). 39027–39027. 32 indexed citations
15.
Xia, Peng, Bin Li, Tingting Geng, et al.. (2015). FGFR2 gene polymorphisms are associated with breast cancer risk in the Han Chinese population.. PubMed Central. 5(5). 1854–61. 36 indexed citations
16.
Yuan, Dawei, Kun Zhu, Chengxue Dang, et al.. (2014). NS5ATP9 mRNA levels in peripheral blood mononuclear cells predict prognosis in patients with gastric cancer. Medical Oncology. 31(8). 106–106. 4 indexed citations
17.
Cheng, Yao, Kang Li, Dongmei Diao, et al.. (2013). Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. Laboratory Investigation. 93(12). 1276–1287. 38 indexed citations
18.
Zhu, Kun, Dongmei Diao, Chengxue Dang, et al.. (2012). Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer. Cancer Science. 104(3). 353–359. 35 indexed citations
19.
Wang, Zhe, Junke Fu, Dongmei Diao, & Chengxue Dang. (2011). Plasma D‐dimer level in the perioperative period in non‐small‐cell lung cancer. Thoracic Cancer. 2(4). 207–212. 7 indexed citations
20.
Dang, Chengxue, et al.. (2006). Adenocarcinoma of the Esophagogastric Junction in China According to Siewert's Classification. Japanese Journal of Clinical Oncology. 36(6). 364–367. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Song Breakdown of academic impact, for papers by Chie Takasu Breakdown of academic impact, for papers by Chew-Wun Wu Breakdown of academic impact, for papers by Liang-Shun Wang Breakdown of academic impact, for papers by Kun‐Chun Chiang Breakdown of academic impact, for papers by Graham P. Pidgeon Breakdown of academic impact, for papers by Lin Jiang Breakdown of academic impact, for papers by Xu Guan Breakdown of academic impact, for papers by Hao Weng Breakdown of academic impact, for papers by Elizabeth Half
Rankless by CCL
2026